Nobivac NXT HCPFeLV
Authorised
This medicine is authorised for use in the European Union
feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline leukemia (self-amplifying RNA particle) vaccine
MedicineVeterinaryAuthorised
Lithuanian is available via eTranslation, the European Commission's machine translation service.
Translate to Lithuanian | Important information about machine translation
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website
Product details
- Name of medicine
- Nobivac NXT HCPFeLV
- Active substance
- feline herpesvirus 1 (FHV), strain G2620A, live
- feline calicivirus (FCV), strain F9, live
- feline panleucopenia virus (FPL), strain MW-1, live
- feline leukemia virus (FeLV) self-amplifying RNA (saRNA)-particle
- International non-proprietary name (INN) or common name
- feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline leukemia (self-amplifying RNA particle) vaccine
Pharmacotherapeutic group
- Immunologicals for felidae
- Other immunologicals
News on Nobivac NXT HCPFeLV
This page was last updated on